[Advance and clinic of antiepileptic drugs (author's transl)].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D002220:Carbamazepine / Q000494:pharmacology; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D051379:Mice; D018377:Neurotransmitter Agents / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D011963:Receptors, GABA-A; D014635:Valproic Acid / Q000494:pharmacology
D000927:Anticonvulsants; D007473:Ion Channels; D018377:Neurotransmitter Agents; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital